Jeppesen, Palle B.;
Gottschalck, Ida B.;
Holst, Jens J.;
Mortensen, Per B.;
Hartmann, Bolette
756 Two Dose-Equivalent, 21-Days, Subcutaneous (S.C.), Glucagon-Like Peptide 2 (GLP-2) Dosing Regimens, 1.0 Mg Continuously Versus 0.33 Mg Three Time Daily (tid), in the Treatment of Short Bowel Syndrome (SBS) Patients
Sie können Bookmarks mittels Listen verwalten, loggen Sie sich dafür bitte in Ihr SLUB Benutzerkonto ein.
Medientyp:
E-Artikel
Titel:
756 Two Dose-Equivalent, 21-Days, Subcutaneous (S.C.), Glucagon-Like Peptide 2 (GLP-2) Dosing Regimens, 1.0 Mg Continuously Versus 0.33 Mg Three Time Daily (tid), in the Treatment of Short Bowel Syndrome (SBS) Patients
Beteiligte:
Jeppesen, Palle B.;
Gottschalck, Ida B.;
Holst, Jens J.;
Mortensen, Per B.;
Hartmann, Bolette